| Literature DB >> 19644541 |
Esther M O'Regan1, Vijay Vanguri, Carl M Allen, Lewis Roy Eversole, John M Wright, Sook-Bin Woo.
Abstract
We describe clinical, morphologic, and immunohistochemical features of 21 cases of solitary fibrous tumor presenting in the oral cavity. There were 9 male and 12 female patients with a median age of 51 years (range 37-83). The most common locations included the buccal mucosa (the most common site), lip, maxillary or mandibular vestibule and tongue. Histopathologic examination showed well-circumscribed tumors with two well-defined patterns: the classic pattern with densely cellular areas alternating with hypocellular areas in a variably collagenous, vascular stroma and a more uniformly sclerotic pattern with only subtle classic areas. The spindle-shaped neoplastic cells consistently showed immunoreactivity for antibodies directed against CD34. Five of nineteen cases (26%) were reactive for CD99 and 19 of 19 for Bcl-2. Follow-up information was available in 17 cases and averaged 54 months, with no evidence of recurrence or metastasis in any of these patients. Awareness that solitary fibrous tumor may present in the oral cavity is important so that confusion with other spindle cell neoplasms can be avoided. We also briefly describe the differential diagnosis and compare this series, the largest single series of intraoral SFT, to cases previously reported in the literature.Entities:
Keywords: CD34; Differential diagnosis; Oral cavity; Solitary fibrous tumor
Mesh:
Substances:
Year: 2009 PMID: 19644541 PMCID: PMC2715455 DOI: 10.1007/s12105-009-0111-8
Source DB: PubMed Journal: Head Neck Pathol ISSN: 1936-055X
Antibodies used for immunohistochemical studies
| Antibody | Clone | Source | Pre-treatment | |
|---|---|---|---|---|
| CD34 | Mouse anti-human IgG1/κ | QBEnd 10 | Dako, Carpinteria, California | None |
| CD99 | Mouse anti-human IgG1 | O13 | Signet, Dedham, Massachusetts | PC |
| Bcl-2 | Mouse anti-human IgG1/κ | 124 | Dako | PC |
| Epithelial membrane antigen (EMA) | Mouse anti-human IgG2a/κ | E29 | Dako | None |
| α-smooth muscle actin (SMA) | Mouse anti-human IgG2a | 1A4 | Sigma, St. Louis, Missouri | None |
| S-100 protein | Rabbit anti-human Ig | Polyclonal | Dako | None |
| Cytokeratin | Mouse anti-human IgG1/κ | AE1/AE3 | Dako | Pr |
PC pressure cooker antigen retrieval in 10 mM citrate buffer pH6.0, Pr digestion with 0.1% protease from Bacillus licheniformus (10 min at 37°C)
Clinical features of 21 patients with oral SFT
| Case Number | Age (yrs) | Sex | Site | Laterality | Size (cm) | Follow-up |
|---|---|---|---|---|---|---|
| 1 | 83 | F | Vestibule | R | 1.2 | LTF |
| 2 | 57 | M | Tongue | R | 2.3 | NED at 36 months |
| 3 | 47 | M | Pharynx | R | 5.4 | NED at 3 months |
| 4 | 51 | F | Buccal mucosa | R | 1.5 | LTF |
| 5 | 60 | M | Lip | R | 2.5 | NED at 84 months |
| 6 | 69 | M | Vestibule | R | 0.9 | LTF |
| 7 | 46 | M | Vestibule | R | 4.0 | NED at 21 months |
| 8 | 58 | M | Alveolar mucosa | R | 1.0 | NED at 58 months |
| 9 | 51 | F | Buccal mucosa | L | 1.5 | NED at 9 months |
| 10 | 43 | F | Alveolar mucosa | R | 2.0 | NED at 78 months |
| 11 | 57 | M | Buccal mucosa | R | 2.1 | NED at 62 months |
| 12 | 43 | F | Buccal mucosa | R | 2.0 | NED at 48 months |
| 13 | 74 | M | Vestibule | R | 2.5 | NED at 102 months |
| 14 | 43 | F | Buccal mucosa | R | 0.8 | NED at 90 months |
| 15 | 47 | F | Tongue | L | 1.0 | NED at 57 months |
| 16 | 46 | F | Buccal mucosa | R | 2.5 | NED at 30 months |
| 17 | 54 | M | Lip | R | 0.7 | NED at 27 months |
| 18 | 48 | M | Lip | L | 1.5 | LTF |
| 19 | 64 | M | Infratemporal fossaa | L | 3.5 | NED at 39 months |
| 20 | 44 | M | Buccal mucosa | R | 1.8 | NED at 28 months |
| 21 | 37 | F | Buccal mucosa | R | 1.0 | NED at 144 months |
LTF lost to follow up, NED No evidence of disease, R right, L Left, N/A not available
aThis mass protruded slightly into the maxillary vestibule, but the bulk of it was in the infratemporal fossa
Histopathologic features of twenty-one patients with intraoral SFT
| Case number | Circumscribed | Pattern | Stroma | Mitoses | Other features | |
|---|---|---|---|---|---|---|
| Y/N | Classic/Classic cellular/Sclerotic | Myxoid | Hyalinized | Number per 10 hpf | Giant cells/Fat/Mast cells/Lymphocytes | |
| 1 | Ya | CC | − | + | 1 | – |
| 2 | Y | C | + | − | 0 | G/L |
| 3 | Ya | C | + | + | 0 | G/F/M/L |
| 4 | Y | S | + | + | 0 | M/L |
| 5 | Y | S | + | + | 0 | G/L |
| 6 | Y | S | − | + | 0 | G/F/L |
| 7 | Y | CC | − | − | 0 | L |
| 8 | Y | S | + | + | 0 | M/L |
| 9 | Y | C | − | − | 0 | G/M/L |
| 10 | Y | S | − | + | 0 | M/L |
| 11 | Y | C | + | − | 2 | G/F/L |
| 12 | Y | C | + | + | 0 | L |
| 13 | Y | S | + | + | 4 | L |
| 14 | Y | S | − | + | 0 | F/L |
| 15 | Y | CC | − | + | 0 | L |
| 16 | Y | C | + | + | 2 | L |
| 17 | Y | C | + | + | 0 | G/L |
| 18 | Y | C | + | + | 0 | L |
| 19 | Y | S | − | + | 0 | L |
| 20 | Y | Cb | + | − | 0 | L |
| 21 | Y | C | + | + | 2 | G/L |
C Classic, CC Classic cellular, S Sclerotic, G Giant cells, F Fat, M Mast cells, L Lymphocytes
aFull or partial capsule
bClassic pattern with sharp demarcation of hyper- and hypocellular myxoid areas; this unusual case is further described in the results section
Fig. 1a SFT with typical well-circumscribed appearance. Also shown here is fat entrapped within the tumor b Muscle entrapment is a feature seen in SFTs
Fig. 2Typical alternations of hypercellular and hypocellular areas in a sclerotic background
Fig. 3a Characteristic whorls found in the more hypercellular areas b Dense perivascular hyalinized material found in many of the classic cases c Ropey collagen, a consistent feature of the classic pattern d Typical cellular appearance seen in three of the thirteen classic cases
Fig. 4Case 18 showed a predominantly myxoid pattern
Fig. 5Case 20 is an unusual case, showing sharp demarcation between hypercellular and hypocellular areas
Fig. 6Thick eosinophilic collagen bundles typical of the sclerotic appearance of some SFTs
Fig. 7Remnant minor salivary ducts with prominent peri-ductal hyalinization
Fig. 8High power view showing the cytological features of SFT
Fig. 9Multi-nucleated giant cells were seen in almost half of the cases
Immunohistochemistry results
| Case number | CD34 | CD99 | Bcl-2 | EMA | SMA | S-100 protein | AE1/AE3 keratin |
|---|---|---|---|---|---|---|---|
| 1 | 3+ | neg | 3+ | neg | neg | neg | neg |
| 2 | 3+ | N/A | N/A | N/A | neg | neg | neg |
| 3 | 3+ | N/A | N/A | N/A | neg | neg | neg |
| 4 | 1+ | neg | 1+ | neg | neg | neg | neg |
| 5 | 3+ | neg | 3+ | neg | neg | neg | neg |
| 6 | 3+ | neg | 3+ | neg | neg | neg | neg |
| 7 | 3+ | neg | 3+ | neg | neg | neg | neg |
| 8 | 3+ | neg | 3+ | neg | neg | neg | neg |
| 9 | 3+ | 1+ | 3+ | neg | neg | neg | neg |
| 10 | 3+ | neg | 3+ | neg | neg | neg | neg |
| 11 | 3+ | neg | 3+ | neg | neg | neg | neg |
| 12 | 3+ | 1+ | 3+ | neg | neg | neg | neg |
| 13 | 3+ | 1+ | 3+ | neg | neg | neg | neg |
| 14 | 3+ | neg | 3+ | neg | neg | neg | neg |
| 15 | 3+ | neg | 3+ | neg | neg | neg | neg |
| 16 | 3+ | neg | 3+ | neg | neg | neg | neg |
| 17 | 3+ | neg | 3+ | neg | neg | neg | neg |
| 18 | 3+ | 1+ | 3+ | neg | neg | neg | neg |
| 19 | 3+ | neg | 3+ | neg | neg | neg | neg |
| 20 | 3+ | 2+ | 3+ | neg | neg | neg | neg |
| 21 | 3+ | neg | 3+ | neg | neg | neg | neg |
Comparison between current series and previously reported cases
| Current series ( | Previously reported cases ( | |
|---|---|---|
| Gender ratio M:F | 12:9 | 24:32 |
| Age in years (range) | Mean 53.4, Median 51 (37–83) | Mean 53.7, Median 54.5 (19–94) |
| Site | ||
| Buccal mucosa | 8 (38.1) | 33 (58.9) |
| Vestibule | 4 (19.2) | – |
| Lip | 3 (14.3) | 2 (3.6) |
| Tongue | 2 (9.5) | 9 (16.1) |
| Alveolar Mucosa | 2 (9.5) | 3 (5.3) |
| Oropharynx | 1(4.7) | 1 (1.8) |
| Infratemporal fossa | 1 (4.7) | – |
| Retromolar | – | 2 (3.6) |
| Palate | – | 4 (7.1) |
| Floor of mouth | – | 2 (3.6) |
| Mean Size in cm (range) | 1.98 (0.7–5.4) | 2.4 (0.7–7.5) |
aClinical information was unavailable in two of the 58 previously reported cases